The effects of administration of theLactobacillus gasseristrain CP2305 on quality of life, clinical symptoms and changes in gene expression in patients with irritable bowel syndrome

Abstract excerpt

AIMS: To clarify the effects of Lactobacillus gasseri CP2305 (CP2305) on quality of life and clinical symptoms and its functional mechanisms in patients with irritable bowel syndrome (IBS). METHODS AND RESULTS: After the patients were administered CP2305 daily for 4 weeks, the IBS-severity index score was significantly improved compared with that of the placebo group, and this improvement was accompanied by a...

Topics

Share this publication in a Topic to start or enrich a Post.

• Share to Gastrointestinal motility and disorders
• Share to Gut microbiota and health
• Share to Probiotics and Fermented Foods